A/Prof Michelle Wykes: How understanding of PD-L2 in malaria is helping research into autoimmune disease

Associate Professor Michelle Wykes is group leader of the molecular immunology laboratory at QIMR Berghofer. She recently received a $500,000 CSL Research Acceleration Initiative partnership to advance treatment of autoimmune diseases including SLE, Sjogren’s syndrome and dermatomyositis.

Read more

Your team is focused on developing novel immunotherapies for autoimmune diseases. What can you tell us about the research to date? My laboratory was for many years focused on understanding the immunology of malaria. It was through that research that we discovered that a molecule known as programmed cell death 1 ligand 2 (PD-L2) controlled ...

Already a member?

Login to keep reading.

© 2021 the limbic